Thomas P Ahern

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors
    Thomas P Ahern
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 20:1937-43. 2011
  2. ncbi Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study
    Thomas P Ahern
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Ave, Rm 355, Boston, MA 02115, USA
    J Natl Cancer Inst 103:1461-8. 2011
  3. ncbi The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable
    Thomas P Ahern
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Epidemiol 174:1382-90. 2011
  4. ncbi No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, T3E, Boston, MA 02118, USA
    Cancer Epidemiol Biomarkers Prev 18:2562-4. 2009
  5. ncbi Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts
    Clin Epidemiol 2:241-6. 2010
  6. ncbi Trends in breast-conserving surgery in Denmark, 1982-2002
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, TE3, Boston, MA 02118, USA
    Eur J Epidemiol 23:109-14. 2008
  7. ncbi Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts 02118, USA
    Med Care 47:73-9. 2009
  8. ncbi Lifetime tobacco smoke exposure and breast cancer incidence
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street T3E, Boston, MA 02118, USA
    Cancer Causes Control 20:1837-44. 2009
  9. ncbi Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
    Clin Epidemiol 1:93-100. 2009

Detail Information

Publications9

  1. ncbi Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors
    Thomas P Ahern
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer Epidemiol Biomarkers Prev 20:1937-43. 2011
    ..We measured the association between functional polymorphisms in key UGTs (UGT2B15*2, UGT2B7*2, and UGT1A8*3) and the recurrence rate among breast cancer survivors...
  2. ncbi Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study
    Thomas P Ahern
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Ave, Rm 355, Boston, MA 02115, USA
    J Natl Cancer Inst 103:1461-8. 2011
    ..Though many studies have reported an association between statin use and breast cancer incidence, the relationship between statin use and breast cancer recurrence has not been well studied...
  3. ncbi The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable
    Thomas P Ahern
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Am J Epidemiol 174:1382-90. 2011
    ..These results do not support the existing hypothesis that VKA therapy is associated with reduced cancer risk...
  4. ncbi No increase in breast cancer recurrence with concurrent use of tamoxifen and some CYP2D6-inhibiting medications
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, T3E, Boston, MA 02118, USA
    Cancer Epidemiol Biomarkers Prev 18:2562-4. 2009
    ..Together, these results provide evidence for a null association between drug-compromised CYP2D6 activity and breast cancer recurrence among tamoxifen-treated women...
  5. ncbi Concordance of metabolic enzyme genotypes assayed from paraffin-embedded, formalin-fixed breast tumors and normal lymphatic tissue
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts
    Clin Epidemiol 2:241-6. 2010
    ..We evaluated the concordance between breast tumor-derived and normal lymph node-derived genotypes for three polymorphic tamoxifen-metabolizing enzymes...
  6. ncbi Trends in breast-conserving surgery in Denmark, 1982-2002
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street, TE3, Boston, MA 02118, USA
    Eur J Epidemiol 23:109-14. 2008
    ..By 2002, BCS prevalence appeared to reach a threshold at 25% of breast cancer operations, seemingly defined by the proportion of new breast cancer cases who are good candidates for BCS...
  7. ncbi Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts 02118, USA
    Med Care 47:73-9. 2009
    ..The effect of time-varying comorbidity status on mortality in breast cancer survivors, however, has not been well investigated...
  8. ncbi Lifetime tobacco smoke exposure and breast cancer incidence
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, 715 Albany Street T3E, Boston, MA 02118, USA
    Cancer Causes Control 20:1837-44. 2009
    ..We analyzed data from a case-control study to assess the association between lifetime tobacco smoke exposure and breast cancer incidence...
  9. ncbi Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivors
    Thomas P Ahern
    Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
    Clin Epidemiol 1:93-100. 2009
    ..Low subject prevalence in the highest strata of a comorbidity index often prompts combination of upper categories into a single stratum ('collapsing')...